UNSPSC 85543082: Occlusion of left neck lymphatic with extraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of left neck lymphatic with extraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07L23CZ

UNSPSC 85543082 Occlusion of left neck lymphatic with extraluminal device, percutaneous approach is a Commodity code that shows little relevant recent activity under state and local procurement. The code nominally describes a specific medical device procedure, but the recent state and local opportunities posted under this code reflect no alignment with that scope. Instead, the opportunities cover occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, disability medical evaluations, surgical carve-out benefits, and youth detention healthcare services—none of which involve lymphatic occlusion devices or the procedural intervention the code name describes. The mismatch suggests either miscoding by issuing bodies or use of this taxonomy designation in a non-standard way that does not track actual procurement of the medical device or related implantable systems the code nominally covers.

The jurisdictions posting under this code span Arizona (City of Phoenix Retirement Office), California (City of Long Beach and County of Santa Clara), Washington (Washington State Department of Transportation), Texas (Harris County Juvenile Probation Department), and Florida (Collier County Board of County Commissioners). Recent activity includes the Washington State Ferries' RFP for occupational medical surveillance with proposals due October 9, 2026, the City of Phoenix Retirement Office's RFP for independent medical evaluation services with proposals due October 16, 2026, and the Collier County RFP for pharmacy benefit management (historical spend approximately $8.7 million annually, contract term January 1, 2026 through December 31, 2028). Given the substantive disconnect between the code's medical device scope and the health services and staffing work actually being solicited, this code does not represent a reliable vehicle for tracking state and local procurement of lymphatic intervention devices or related products.